Login USERNAME  PASSWORD  REMEMBER ME
LJN's Product Liability Law & Strategy
LJN Web Audio
Articles from Related Newsletters
Online International Trademark Issues: Some Practical Considerations
Internet Law & Strategy
What happens when a U.S. company’s trademark is misused on the Internet outside of the United States? Short of litigating in that country, is all hope lost in addressing the problem? Given the obvious jurisdictional roadblocks that exist in litigating in the U.S. against a foreign person or entity, there are some practical tactics that could prove useful in addressing and preventing this type of problematic behavior.

Right-of-Publicity Claims and Advertiser Sponsored User-Generated Content Campaigns
e-Commerce Law & Strategy
This article concentrates on the scope of Communications Decency Act(CDA) immunity advertisers that operate user-generated content (UGC) campaigns may enjoy, limitations of the CDA in protecting against these claims and ways to structure UGC campaigns to minimize the risk of liability arising from unauthorized use of individuals’ name, likeness and other personal attributes possibly included in UGC submitted as part of a sponsored UGC campaign.

Impact of Bankruptcy on Third-Party Trademark License Assignments
Entertainment Law & Finance
Intellectual property — and thus entertainment industry — licensors are perpetually concerned about whether their licensees could use the bankruptcy process to assign their license rights to third parties, especially to third parties to whom the licensor would not want to grant a license. This concern can be particularly acute for trademark licensors, who want to protect their trademarks.

2011 Litigation Trends Survey
The Corporate Counselor
Results of the 2011 Fulbright & Jaworski Litigation Trends Survey of senior corporate counsel.

Top Stories
We're sorry. Your computer must be equipped with a browser capable of rendering HTML 4.01 and running JavaScript. In your browser, you must enable JavaScript. In addition, you should enable style sheets.

Headlines
The FDA’s New Guidelines on Financial Disclosure by Clinical Investigators
The FDA has recently updated its Guidance for Industry: Financial Disclosure of Clinical Investigators for the first time since 2001. This article briefly examines the key changes and their practical implications in product liability cases.

Practice Tip: Product Liability Litigation
Although recent statistics are difficult to obtain, it is clear that the amount of product liability litigation filed in the United States is unparalleled around the world. hy is there such a difference as compared with Canada and the UK?

Lies, Damned Lies, and Addictions
This three-part article explores the role of addiction in product liability litigation, and the paradoxes involved.

February Issue in PDF Format